Skip to content

Clinical trials

Respiratory Tract Neoplasms trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Tract Neoplasms Country / region: France Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20151
20174
20191
20202
20212
20221
20232
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting4
Terminated4
Active, not recruiting3
Completed3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company3
Revolution Medicines, Inc.3
Blueprint Medicines Corporation2
Hoffmann-La Roche2
ArriVent BioPharma, Inc.1
AstraZeneca1
Turning Point Therapeutics, Inc.1
University Hospital, Rouen1
sigma-tau i.f.r. S.p.A.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Tract Neoplasms15
Carcinoma, Non-Small-Cell Lung13
Lung Neoplasms13
Lung Diseases12
Neoplasms by Site12
Respiratory Tract Diseases12
Bronchial Neoplasms11
Neoplasms11
Thoracic Neoplasms11
Carcinoma, Bronchogenic9

Trials

Showing 51 to 15 of 15. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.